BRAF Multiplex Mutation Screening Kit

BRAF Multiplex Mutation Screening Kit    

BRAF gene mutation associated with human cancers have been identified. The frequency of BRAF mutations varies widely in human cancers, from more than 80% in melanomas and nevi, to as little as 0~18% in other tumors, such as 1~3% in lung cancers and 5% in colorectal cancer. BRAF Digital PCR Multiplex Mutation Screening Kit identifies possible 62 mutation sites in a single well in a rapid and cost-effective manner. The targets are determined by unlabeled multiplex primers and fluorescent labeled probes.

Features

• Superior performance: allows quantification and screening for multiple BRAF mutations in a single well
• High sensitivity: provides sensitive and precise detection down to 0.2% in a single well
• Simple workflow: allows screening of multiple samples in a rapid and cost-effective manner. Reaction time ~4 hours

*  This products is for research use only in US